Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Deutsche And Citi Go Opposite Ways On Indivior

Thu, 30th Jul 2015 08:40

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
UBS RAISES GKN TO 'BUY' ('NEUTRAL') - TARGET 360 (370) PENCE
----------
EXANE BNP CUTS GKN PRICE TARGET TO 345 (370) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS ST JAMES'S PLACE TO 'HOLD' ('BUY') - TARGET 950 PENCE
----------
DEUTSCHE BANK RAISES TAYLOR WIMPEY PRICE TARGET TO 231 (210) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1490) PENCE - 'HOLD'
----------
SOCGEN CUTS GLAXOSMITHKLINE PRICE TARGET TO 1250 (1550) PENCE - 'SELL'
----------
S&P CAPITAL IQ CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1400) PENCE - 'SELL'
----------
JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1135 (1165) PENCE - 'NEUTRAL'
----------
NOMURA CUTS COMPASS GROUP PRICE TARGET TO 1162 (1268) PENCE - 'BUY'
----------
SOCGEN CUTS COMPASS GROUP PRICE TARGET TO 1010 (1040) PENCE - 'SELL'
----------
UBS CUTS ANTOFAGASTA PRICE TARGET TO 630 (740) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 625 (650) PENCE - 'HOLD'
----------
CITIGROUP RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 4200 (4100) PENCE - 'BUY'
----------
GOLDMAN RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 3250 (3230) PENCE
----------
GOLDMAN RAISES BARCLAYS PRICE TARGET TO 335 (330) PENCE - 'BUY'
----------
JPMORGAN RAISES BARCLAYS PRICE TARGET TO 330 (285) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 310 (287) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES BARCLAYS PRICE TARGET TO 290 (260) PENCE - 'HOLD'
----------
UBS RAISES BARCLAYS PRICE TARGET TO 310 (295) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES SKY PLC PRICE TARGET TO 1160 (1140) PENCE - 'HOLD'
----------
SOCGEN CUTS SABMILLER PRICE TARGET TO 3500 (3570) PENCE - 'HOLD'
----------
FTSE 250
----------
NUMIS CUTS PREMIER FARNELL PRICE TARGET TO 180 (215) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS TULLOW OIL PRICE TARGET TO 365 (380) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES RIGHTMOVE PRICE TARGET TO 2950 (2670) PENCE - 'HOLD'
----------
BERENBERG RAISES RIGHTMOVE PRICE TARGET TO 3380 (3200) PENCE - 'HOLD'
----------
NOMURA RAISES RIGHTMOVE PRICE TARGET TO 3700 (3500) PENCE - 'BUY'
----------
EXANE BNP RAISES VIRGIN MONEY PRICE TARGET TO 515 (500) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS TULLOW OIL PRICE TARGET TO 457 (480) PENCE - 'OUTPERFORM'
----------
GOLDMAN CUTS TULLOW OIL PRICE TARGET TO 354 (368) PENCE - 'BUY'
----------
JPMORGAN CUTS TULLOW OIL PRICE TARGET TO 380 (424) PENCE - 'NEUTRAL'
----------
UBS CUTS TULLOW OIL PRICE TARGET TO 270 (335) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS MITCHELLS & BUTLERS PRICE TARGET TO 440 (470) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS LANCASHIRE HLDGS PRICE TARGET TO 610 (642) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES NATIONAL EXPRESS PRICE TARGET TO 295 (287) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JUPITER FUND PRICE TARGET TO 475 (465) PENCE - 'OVERWEIGHT'
----------
CITIGROUP RAISES INFORMA PRICE TARGET TO 500 (475) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES INDIVIOR TO 'BUY' ('HOLD') - TARGET 300 (220) PENCE
----------
CITIGROUP CUTS INDIVIOR TO 'NEUTRAL' ('BUY') - TARGET 270 (240) PENCE
----------
JEFFERIES RAISES INDIVIOR PRICE TARGET TO 300 (250) PENCE - 'BUY'
----------
NOMURA RAISES WIZZ AIR PRICE TARGET TO 1700 (1600) PENCE - 'BUY'
----------
NOMURA CUTS PETRA DIAMONDS PRICE TARGET TO 190 (250) PENCE - 'BUY'
----------
UBS RAISES GREGGS PRICE TARGET TO 1310 (1280) PENCE - 'BUY'
----------
UBS CUTS LADBROKES PRICE TARGET TO 135 (140) PENCE - 'BUY'
----------
SOCGEN RAISES TATE & LYLE TO 'BUY' ('HOLD') - PRICE TARGET 620 (600) PENCE
----------
TRADERS: HSBC CUTS BRITVIC PRICE TARGET TO 860 (875) PENCE
----------
TRADERS: HSBC RAISES SEGRO PRICE TARGET TO 451 (432) PENCE
----------
LIBERUM CUTS SENIOR PLC PRICE TARGET TO 295 (360) PENCE - 'HOLD'
----------
LIBERUM RAISES PACE PLC TO 'BUY' ('HOLD') - TARGET 412 PENCE
----------
MAIN MARKET AND AIM
----------
NUMIS CUTS RPS GROUP PRICE TARGET TO 265 (285) PENCE - 'BUY
----------
PANMURE CUTS RPS GROUP PRICE TARGET TO 180 (190) PENCE - 'BUY'
----------
LIBERUM CUTS RPS GROUP PRICE TARGET TO 280 (300) PENCE - 'BUY'
----------
NUMIS RAISES ACCESSO TECHNOLOGY PRICE TARGET TO 910 (730) PENCE - 'BUY'
----------
PANMURE INITIATES GEAR4MUSIC WITH 'BUY' - TARGET 180 PENCE
----------
LIBERUM CUTS XCHANGING TO 'HOLD' ('BUY') - TARGET 100 (220) PENCE
----------
LIBERUM INITIATES COMMUNISIS WITH 'BUY' - TARGET 75 PENCE
----------
BERENBERG RAISES CVS GROUP PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.